DOI: 10.1055/s-00000011

DMW - Deutsche Medizinische Wochenschrift

References

Gordon LI, Witzig T, Molina A. et al.
Yttrium 90-labeled ibritumomab tiuxetan radioimmunotherapy produces high response rates and durable remissions in patients with previously treated B-cell lymphoma. 
Clin Lymphoma 2004; 5: 98-101  

Download Bibliographical Data

Search in: